Investors / United Kingdom / Eos
Eos
Venture capital · St Andrews, United Kingdom · Europe
Eos invests in and commercialises science and technology companies, from local seed-stage to global scale. It connects non-specialist investors with knowledge-intensive science and technology businesses through an angel syndicate, an EIS fund and venture partner arrangements.
Invests inHealthcare & Biotech
In its own wordssciencetechnologyhealthcaresustainabilityimpactlife sciences
Your fit with Eos
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsEos lists 20 checked portfolio companies on its own site and is named in 6 funding rounds, 4 of them as lead. Its most frequent entry is Seed, 83% of the companies with a known first round. Its largest themes are Healthcare & Biotech (75%), Industrial & Manufacturing (13%) and Robotics & Hardware (4%). 92% of its companies are based in United Kingdom. It invests most often alongside Mercia Ventures, Old College Capital and Future Planet Capital.
Counts come from funding rounds that name Eos, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Eos' whole history. Rounds on record name 6 companies; its own site lists 20. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 83% |
| Series A | 17% |
| Series B | 0% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 1 | 1 |
| '26 | 5 | 3 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 51th | 20 companies |
| Recent activity | 86th | 5 rounds in 12 months |
| Early stage | 84th | 83% of entries at pre-seed or seed |
| Evidence | 86th | 15% of companies confirmed by a round |
| Sector focus | 93th | 75% in its largest sector |
| Reach | 42th | 2 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Mercia Ventures | 4 |
| Old College Capital | 3 |
| Future Planet Capital | 2 |
| Norcliffe Capital | 2 |
| Science Creates Ventures | 2 |
| Scottish National Investment Bank | 2 |
| UKI2S | 2 |
| 8VC | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers20100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 75% | 15% |
| Industrial & Manufacturing | 13% | 7% |
| Robotics & Hardware | 4% | 1% |
| Food & Agriculture | 4% | 3% |
| Education | 4% | 7% |
Co-investor network
who it backs companies with, and who they back togetherCompare Eos head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Eos| Date | Company | Stage |
|---|---|---|
| 2 Nov 2026 | Series A | |
| 14 Oct 2026 | Seed | |
| 6 Jul 2026 | Seed Led | |
| 7 May 2026 | Seed Led | |
| 12 Feb 2026 | Seed Led | |
| 28 Aug 2025 | Seed Led |
Round details for Eos
Amounts, full round histories and every co-investor in Eos' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
20 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Bioliberty develops technology designed to support the sustainable delivery of high-repetition therapy for neurological recovery | Healthcare & Biotech | Portfolio page | ||
| Bioliberty develops technology designed to support the sustainable delivery of high-repetition therapy for neurological recovery | Healthcare & Biotech | Nov 2026Series A | Funding round | |
| CamGene develops RNA-based medicines for hearing loss | Healthcare & Biotech | Portfolio page | ||
| Carcinotech provides preclinical oncology services, including drug discovery and testing using human-relevant 3D tumour models | Healthcare & Biotech | Portfolio page | ||
| Chemify digitizes molecule creation using chemistry, robotics, computation, machine learning and a programming language | Robotics & HardwareHealthcare & Biotech | Portfolio page | ||
| Concinnity Genetics designs unique RNA-based control systems that enable the precise control of gene therapies. | Healthcare & Biotech | Portfolio page | ||
| Cumulus Oncology develops oncology assets with a focus on improving success rates in drug discovery and development | Healthcare & Biotech | Portfolio page | ||
| Dxcover develops a platform for earlier diagnosis of multiple cancers, including brain, pancreatic, and ovarian cancer, using machine learning and light-based technology. | Healthcare & Biotech | Portfolio page | ||
| ENOUGH produces mycoprotein through a zero-waste fermentation process to provide a sustainable protein source | Food & Agriculture | Portfolio page | ||
| EnsiliTech develops a technology to prevent degradation of thermally unstable biomolecules | Healthcare & Biotech | Aug 2025Seed | Page + round | |
| ILC Therapeutics Ltd is a cytokine-engineering company pioneering Hybrid Interferons as first-in-class therapeutics | Healthcare & Biotech | Portfolio page | ||
| Laverock Therapeutics develops advanced therapies through its unique platform technologies | Healthcare & Biotech | Portfolio page | ||
| Nami Surgical develops ultrasonic technology for surgical precision, including an articulating ultrasonic scalpel for robotic surgery. | Healthcare & Biotech | Oct 2026Seed | Page + round | |
| Naturbeads replaces microplastics particles with natural, biodegradable ingredients through innovative particle technology. | Industrial & ManufacturingHealthcare & Biotech | Portfolio page | ||
| NeuPulse develops a wearable, non-invasive, drug-free device for supporting brain health | Healthcare & Biotech | Feb 2026Seed | Page + round | |
| Novosound develops a handheld ultrasound device for blood pressure monitoring | Healthcare & Biotech | Portfolio page | ||
| Scarlet Therapeutics is developing a pioneering platform that generates novel red blood cell-based therapeutics to treat a wide range of diseases. | Healthcare & Biotech | May 2026Seed | Funding round | |
| Novel Technologies develops and provides antimicrobial technology for various industries, including apparel, coatings, hospitality, and medical fields. | Healthcare & BiotechIndustrial & Manufacturing | Portfolio page | ||
| TaiSan builds next-generation sodium batteries around a novel polymer electrolyte | EducationIndustrial & Manufacturing | Jul 2026Seed | Funding round | |
| The company uses full-length RNA sequencing from blood to detect novel biomarkers for cancer medicine. | Healthcare & Biotech | Portfolio page |
About this data
site last read 13 Nov 2026- Site
- eos-advisory.com
- Last read
- 13 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 28 Aug 2025
- Companies checked
- 20
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Eos' profile as data
Pull Eos' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/eos-advisory.com
# also
GET /v1/firms/eos-advisory.com/portfolio
GET /v1/firms/eos-advisory.com/coinvestors
GET /v1/firms/eos-advisory.com/news